EP2035060A1 - Verweilkatheter - Google Patents
VerweilkatheterInfo
- Publication number
- EP2035060A1 EP2035060A1 EP07765576A EP07765576A EP2035060A1 EP 2035060 A1 EP2035060 A1 EP 2035060A1 EP 07765576 A EP07765576 A EP 07765576A EP 07765576 A EP07765576 A EP 07765576A EP 2035060 A1 EP2035060 A1 EP 2035060A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- catheter
- transition temperature
- indwelling catheter
- indwelling
- shape
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000007704 transition Effects 0.000 claims abstract description 38
- 239000012781 shape memory material Substances 0.000 claims abstract description 10
- 239000002861 polymer material Substances 0.000 claims 1
- 241000446313 Lamella Species 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 10
- 229920000642 polymer Polymers 0.000 description 9
- 210000000130 stem cell Anatomy 0.000 description 9
- 210000003462 vein Anatomy 0.000 description 9
- 238000000502 dialysis Methods 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- -1 HYPAN Polymers 0.000 description 4
- 238000002617 apheresis Methods 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000001990 intravenous administration Methods 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000005259 peripheral blood Anatomy 0.000 description 3
- 239000011886 peripheral blood Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000735 allogeneic effect Effects 0.000 description 2
- 210000003995 blood forming stem cell Anatomy 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 210000001357 hemopoietic progenitor cell Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- VPVXHAANQNHFSF-UHFFFAOYSA-N 1,4-dioxan-2-one Chemical compound O=C1COCCO1 VPVXHAANQNHFSF-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010001526 Air embolism Diseases 0.000 description 1
- 241001631457 Cannula Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001311 Poly(hydroxyethyl acrylate) Polymers 0.000 description 1
- 229920001665 Poly-4-vinylphenol Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000826860 Trapezium Species 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000001400 myeloablative effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 201000003144 pneumothorax Diseases 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3659—Cannulae pertaining to extracorporeal circulation
- A61M1/3661—Cannulae pertaining to extracorporeal circulation for haemodialysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
- A61B2017/00871—Material properties shape memory effect polymeric
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
- A61M25/0075—Valve means
- A61M2025/0076—Unidirectional valves
- A61M2025/0078—Unidirectional valves for fluid inflow from the body into the catheter lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/008—Strength or flexibility characteristics of the catheter tip
- A61M2025/0081—Soft tip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0266—Shape memory materials
Definitions
- the invention relates to an indwelling catheter with a straight tubular body.
- the invention relates to an intravenous indwelling catheter for collecting blood components, in particular hemopoietic stem cells, by means of cell separators and for dialysis.
- Indwelling catheters find a variety of applications, for example, already in the blood donation but also in the context of dialysis.
- indwelling catheters which are used in the context of hemopoietic progenitor cell transplantation after conditioning chemotherapy.
- Haemopoietic progenitor cell transplantation after conditioning chemotherapy with myeloablative or reduced intensity often offers the best chance of recovery for patients with leukemias, lymphomas and plamocytomas.
- the method requires the mobilization of hemopoietic stem cells from the bone marrow into the peripheral blood. This is mediated by chemotherapy in conjunction with growth factors (G-CSF) in patients with or by growth factors alone in allogeneic donors. Thereafter, the collection of stem cells from the peripheral blood is similar to the longer 3 - 4h blood donation using a blood cell separator possible.
- G-CSF growth factors
- the patient's blood is returned from a venous vessel of the patient into the machine and, after separation to the patient via a second venous access.
- Blood flow velocity It depends primarily on the inside diameter and the length of the catheter. Optimum flow rates are 8 to 100 ml / min. At least 30 ml / min is required.
- Blood flow interruptions They are the result of short-term occlusions of the distal catheter opening by suctioning it onto the catheter wall. This phenomenon is often noticeable as a vibration on the luer connector of the catheter. Flow interruptions extend the separation time.
- dialysis cannula allow high flow rates but have the disadvantage that they can dislocate in particular with longer cell separations and placement in the articular joint or perforate the vein wall.
- Plastic catheters are less risky in this regard but more frequently have low blood flow rates and blood flow interruptions as a result of their length and higher flow turbulence.
- the condition of a patient's veins deteriorates if they have already undergone chemo and steroid therapies.
- peripheral blood collection is no longer possible because the blood flow rates that can be achieved with venous indwelling catheters are too low.
- blood vessel flow is often interrupted by aspiration of the venous wall during blood collection, which delays the construction of the interface in the cell separator.
- large-lumen, double-lumen catheters must be placed in central veins to achieve the required flow rates of 80 to 100 ml / min as a prerequisite to successful stem cell collection.
- These catheters carry risks such as bleeding, pneumothorax and air embolism. In rare cases, these incidents are fatal.
- the object of the invention is to improve indwelling catheters, in particular for use in the context of hemopoietic progenitor cell transplantation, but also in the context of dialysis or blood donation.
- the goal is to improve donor protection and donor comfort during blood donation.
- an improved stem cell collection catheter system is to be created, which enables the collection of stem cells via peripheral veins in the majority of patients from whom autologous stem cells are to be collected and allogeneic stem cell donors and makes the use of central dialysis catheters superfluous.
- the goal is an indwelling catheter that provides improved blood flow characteristics, reduces the frequency of blood flow interruptions, and minimizes the risk of venipuncture.
- an indwelling catheter is not limited to use in the context of stem cell collection, but can be used in all patients with difficult venous conditions or with the need for longer-term parenteral therapy.
- an indwelling catheter made of a shape memory material.
- shape memory material allows the indwelling catheter to have a first shape below a transition temperature and a second shape above the transition temperature.
- the first shape is determined by the fact that circumferentially separated lamellae at the distal end of the indwelling catheter are stretched below the transition temperature in the longitudinal direction of the catheter and bend outward when the transition temperature is exceeded, so that a funnel-shaped, distal Catheter opening results.
- Such a configuration of the distal end of the catheter ideally brings several advantages: The flow of blood into the catheter is accelerated over a longer distance and the turbulences occurring when the blood enters the catheter are reduced.
- the outwardly bending lamellae spread the vein on a tent and enlarge the blood inlet cross section of the catheter.
- the aspiration of the distal catheter opening against the venous wall is prevented as far as possible, so that at least less frequent blood flow interruptions occur.
- the shape memory material causes the indwelling catheter below the transition temperature has a smaller inner and outer diameter than above the transition temperature. This allows the indwelling catheter to be inserted in its relatively slender state into a punctured vein and then expands to a larger diameter. Due to the larger inner diameter larger blood flow velocities are possible with lower pressure loss.
- Suitable inner diameters of the catheter in its first form below the transition temperature are less than 1.5 mm.
- the catheter In its second form above the transition temperature, the catheter preferably has an inner diameter of at least 2 mm.
- the transition temperature of the shape memory material is ideally a few degrees below body temperature, for example, between 28 ° C and 35 ° C. In this way, the indwelling catheter exceeds the transition temperature after insertion into a vein and, as a result, assumes its second widened shape.
- the indwelling catheter preferably has a length of less than 40 mm and more preferably a length of less than 35 mm. Such a small length of the catheter helps to reduce flow turbulence.
- a catheter allows an inverse puncture, that is, a puncture against the direction of blood flow. The inverse puncture allows the blood not to flow retrograde into the catheter as with conventional puncture technique, but to flow othograd - ie from the front - onto the catheter tip. The retrograde flow of the catheter tip implies a reversal of the direction of flow from the intravenous flow to the intraluminal flow within the catheter.
- the lamellae at the distal end of the catheter taper in the distal direction. This means that, at the same time, the circumferentially measured dimension of the gaps between the lamellae increases from the base of the lamellae to the distal end of the catheter. It follows that the lamellae connect at their proximal base, with which they connect to a tubular circumferentially closed, proximal catheter, the largest extent in the circumferential direction and slimming towards the distal end of the catheter.
- a suitable shape of the lamellae is, for example, similar to an elongated triangle or trapezium, preferably with a rounded tip at the distal end. The rounded tip prevents injury to the vessel wall when it is pushed outward by the outwardly curved lamellae at the distal end of the catheter, thereby dilating the vessel.
- Area of the base of the slats - the catheter preferably has openings through which to avoid backflow.
- Such openings can also be arranged slightly proximal to the base of the lamellae in the distal region of the proximal catheter section and serve to increase the passage or inlet cross-section for the inflowing liquid.
- the shape memory material of the catheter is preferably a plastic. In this way it is possible to maintain the advantages of a plastic catheter, in particular the lower risk of injury, without the usual disadvantages of a plastic catheter, such as a small inner diameter to take effect.
- a suitable polymer as shape memory material are polymers with shape memory properties, in particular multiblock polymers. Mention in particular:
- PUPA polyurethane and poly (amido-amine)
- hydrophilic polymer consisting of one or more constituents of: poly (ethylene oxide), polyvinyl pyrrolidone, polyvinyl alcohol, poly (ethylene glycol), polyacrylamide, poly (hydroxyethyl methacrylate), hydrophilic polyurethanes, HYPAN, poly (hydroxyethyl acrylate) , hydroxyethyl cellulose, hydroxypropyl cellulose, methoxy pectin gel, agar, starch, modified starch, alginates, hydroxy ethyl carbohydrates and mixtures and copolymers thereof
- Amorphous polyester urethane networks namely polymeric networks obtainable by reacting hydroxytelechelic prepolymers, said prepolymers comprising polyester and / or polyether segments, with diisocyanate.
- Prepolymers may also contain units derived from lactic acid, caprolactone, dioxanone, glycolic acid, ethylene glycol and / or propylene glycol.
- non-biodegradable, polymer segments or polymers with shape memory properties include:
- Ethylene vinyl acetate poly (methyl) acrylic acid, polyamides, polyethylenes, polypropylenes, polystryrenes, polyvinyl chlorides, polyvinylphenol, copolymers and mixtures thereof.
- Copolymers containing methyl acrylate polymer segments as "soft segments” also exhibit shape-memory properties in the "dried" state.
- a catheter of the type according to the invention permits the novel use of such a catheter in the context of the production of stem cells and in the production of granulocyte, platelet and donor lymphocyte concentrates, as well as freeze plasmas by means of apheresis.
- Another new feature is the use of an indwelling catheter made of shape memory plastic in the context of therapeutic apheresis, for example plasma apheresis, erythrocyte exchange or platelet depletion, as well as in the context of apheresis in the context of new cell therapeutic methods, for example the production of dendritic cells, macrophages or lymphocytes ,
- Figure 1 a plan view of the catheter according to the invention in an enlarged, schematic representation
- FIG. 2 shows a distal end section of the catheter from FIG. 1 in an enlarged representation in its first form below the transition temperature;
- FIG. 3 shows the distal catheter section from FIG. 2 in its second form above the transition temperature
- FIG. 4 shows a schematic representation of the distal catheter section after puncture in the interior of a blood vessel and after transition of the catheter form into the second, widened form above the transition temperature in the case of retrograde inflow;
- FIG. 5 an illustration of the distal catheter section within a blood vessel similar to FIG. 4, but in the case of orthogonal flow.
- the catheter 10 shown in FIG. 1 has a straight catheter shaft 12 whose free length from its distal end 14 to a fixing wing 16 in the vicinity of the proximal catheter end 18 is 3.5 cm.
- the catheter 10 also has a conventional Luer connection 20 at its proximal end.
- the free, straight shaft 12 of the catheter 10 has a relatively long proximal catheter portion 22 which is closed in a tubular manner. At its distal end, this proximal catheter section 22 merges into a comparatively short distal catheter section 24, in which the catheter shaft 12 is subdivided into a plurality of lamellae 26 in the circumferential direction.
- the lamellae 26 may have the shape of an elongated triangle which, with a base 28, has the shape of an elongated triangle.
- the end of the tubular closed, proximal shaft portion 22 connects.
- the catheter shaft 12 consists of a polymer with shape memory properties, so that the catheter shaft 12 assumes the first shape shown in FIGS. 1 and 2 below a transition temperature between 25 and 32 ° C. and above the transition temperature in that shown in FIGS. 3 to 5 second form changes.
- the slats 26 are elongated.
- the lamellae 26 at the distal end of the catheter shaft 12 are bent outwards, as shown in FIGS. 3 to 5.
- the catheter has in its first form below the transition temperature an inner diameter of 22 gauge, corresponding to about 1 mm. After transition to its second form above the transition temperature of the catheter shaft 12 has an inner diameter of, for example, 14 gauge, corresponding to about 2 mm.
- the catheter 10 can be easily inserted into a punctured vein using the cannula 30 inserted into a lumen of the catheter shaft 12.
- the lamellae 26 bulge outwards and thus form a funnel-shaped, distal catheter opening, through which blood can easily enter without being abruptly accelerated.
- the distal ends of the outwardly curved lamellae 26 can widen the respective blood vessel so that, on the one hand, the flow conditions are improved and, on the other hand, suction of the blood vessel wall is largely prevented.
- a catheter of shape memory property polymer such that it expands upon transgression of the transition temperature in the manner described herein without, however, having the lamellae described herein at the distal end of the catheter.
- a catheter made of a polymer with shape memory properties and a shaft that expands when the transition temperature is exceeded thus produces an independent idea of the invention, which can also be realized without lamellae at the distal end of the catheter end, but at the same time produces a synergistic effect with lamellae With regard to improving the fluid mechanics.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006029574A DE102006029574A1 (de) | 2006-06-22 | 2006-06-22 | Verweilkatheter |
| PCT/EP2007/056266 WO2007147894A1 (de) | 2006-06-22 | 2007-06-22 | Verweilkatheter |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2035060A1 true EP2035060A1 (de) | 2009-03-18 |
Family
ID=38480448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP07765576A Withdrawn EP2035060A1 (de) | 2006-06-22 | 2007-06-22 | Verweilkatheter |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110046609A1 (de) |
| EP (1) | EP2035060A1 (de) |
| DE (1) | DE102006029574A1 (de) |
| WO (1) | WO2007147894A1 (de) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4411655A (en) * | 1981-11-30 | 1983-10-25 | Schreck David M | Apparatus and method for percutaneous catheterization |
| JPS6468275A (en) | 1987-09-08 | 1989-03-14 | Terumo Corp | Indwelling catheter in abdominal cavity |
| US5885258A (en) * | 1996-02-23 | 1999-03-23 | Memory Medical Systems, Inc. | Medical instrument with slotted memory metal tube |
| US5814026A (en) * | 1996-03-19 | 1998-09-29 | Yoon; Inbae | Endoscopic portal having a universal seal and methods for introducing instruments therethrough |
| US6072154A (en) * | 1996-09-05 | 2000-06-06 | Medtronic, Inc. | Selectively activated shape memory device |
| EP0962227B1 (de) * | 1998-06-02 | 2002-11-13 | Terumo Kabushiki Kaisha | Verweilkatheter |
| US6540767B1 (en) * | 2000-02-08 | 2003-04-01 | Scimed Life Systems, Inc. | Recoilable thrombosis filtering device and method |
| US6893427B1 (en) * | 2000-03-23 | 2005-05-17 | Vascon, Llc | Catheter with thermoresponsive distal tip portion |
| US20030236533A1 (en) * | 2002-06-20 | 2003-12-25 | The Regents Of The University Of California | Shape memory polymer actuator and catheter |
| CA2527976C (en) * | 2003-06-13 | 2011-11-22 | Mnemoscience Gmbh | Stents |
| JP2005237626A (ja) * | 2004-02-26 | 2005-09-08 | Junji Imanishi | カテーテル |
-
2006
- 2006-06-22 DE DE102006029574A patent/DE102006029574A1/de not_active Ceased
-
2007
- 2007-06-22 US US12/308,812 patent/US20110046609A1/en not_active Abandoned
- 2007-06-22 WO PCT/EP2007/056266 patent/WO2007147894A1/de not_active Ceased
- 2007-06-22 EP EP07765576A patent/EP2035060A1/de not_active Withdrawn
Non-Patent Citations (1)
| Title |
|---|
| See references of WO2007147894A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| DE102006029574A1 (de) | 2007-12-27 |
| US20110046609A1 (en) | 2011-02-24 |
| WO2007147894A1 (de) | 2007-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928376T2 (de) | Dialysekatheter mit hohem durchfluss und verfahren dazu | |
| DE69916244T2 (de) | Absperrorgan für biegsame kanüle | |
| DE60017125T2 (de) | Transplantat-katheter für vaskulares zugangssystem | |
| DE60315498T2 (de) | Teilbare Katheteranordnung mit mehreren Kathetern | |
| DE69229721T2 (de) | Katheter mit veränderbarer lumenanzahl | |
| EP2496152B1 (de) | Medizinische vorrichtung zum rekanalisieren von körperhohlräumen, set umfassend eine derartige vorrichtung und verfahren zur herstellung einer medizinischen vorrichtung | |
| DE3786441T2 (de) | Katheter. | |
| DE69735088T2 (de) | Blutgerinnselfangspirale | |
| DE60028244T2 (de) | Auftrennbares medizinisches ventil | |
| DE3789716T2 (de) | Mechanisch verstärkter Tubus für Heilzwecke. | |
| DE69730936T2 (de) | Versteifungselement zur Erhöhung des Flüssigkeitsdurchsatzes in einer medizinischen Vorrichtung | |
| DE69732864T2 (de) | Mehrlumige Zugangsvorrichtung | |
| DE112021000840T5 (de) | Expandierbare hülse mit verriegelung-dilatator | |
| DE2715198C2 (de) | Kanüle zur Einführung eines flexiblen Gefäßkatheters in ein Blutgefäß | |
| DE2007738A1 (de) | Medizinisch-chirurgische Röhren, insbesondere Katheter | |
| DE212014000034U1 (de) | Einführhilfe | |
| DE3230049A1 (de) | Implantat und gefaesseinsatzstueck zum anschliessen desselben | |
| DE102005051211B4 (de) | Verfahren zur Herstellung eines mehrlumigen Kathetersystems | |
| DE69121852T2 (de) | Katheter zum Einführen durch eine Nadel | |
| EP1595556A1 (de) | Intravenöser Oxygenator | |
| WO2003075993A1 (de) | Sklerosierungskatheter zur sklerosierung von blutgefässen, insbesondere venen | |
| WO2021078526A1 (de) | Katheter | |
| EP0081724B1 (de) | Intraperitonealkatheter | |
| WO2007147894A1 (de) | Verweilkatheter | |
| DE3325920C2 (de) | Drainageschlauch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20090122 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: NOTTER, MICHAEL |
|
| 17Q | First examination report despatched |
Effective date: 20120113 |
|
| DAX | Request for extension of the european patent (deleted) | ||
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOTTER, MICHAEL |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20160105 |